Quality by Design and the new FDA Process Validation Guidance. How do they fit together?
March 12th, 2012 by Peter CalcottAt a recent IBC conference on Product and Process Validation, I moderated a panel discussion on this topic with four panelists in addition to myself. They included two from Pfizer, and one each from Genentech/Roche and Shire Pharmaceuticals. What were the conclusions:
- All companies were finding the efforts of QbD painful and laborious and were only just beginning to touch on the new PV guidance. This was true for the larger companies and especially so for the smaller ones.
- Some were seeing a back pedalling by the regulators on what benefits the companies might reap for this added work.
- All recognised that the very small company might find it exceedingly painful if not impossible.
The panel discussion was published in Pharma QbD and I have included a link so you can read more.
Stay tuned, I will be writing more on the topic.
Please let me know latest guidline of QBD.
Regards
Prem Prakash
QbD is discussed in ICH Q8 and 11, which with Q9 and 10 give you the framework. These are the main sources for guidelines or regulations. However I would google QbD to see any new presentations.
please let me know new USFDA guidelines in PROCESS VALIDATION
The FDA has released the new guidance about 2 years ago. The link is
FDA Guidance for Process Validation http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070336.pdf
The EU has also issued one at http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/04/WC500125399.pdf
Hope this helps
I really had been seeking for points for my site and encountered ur posting, “Quality by Design and the new FDA
Process Validation Guidance. How do they fit together?
| Calcott Consulting LLC”, do you mind in cases where I actually utilize several of your points?
Many thanks -Albert
Yes, you may quote but reference source with a link to my site or blog